AzTrials
AzTrials

Ischemic StrokeBIC4CVAPREMSNCT05734352

Patient Experiences on the Stroke Unit

An observational study of Ischemic Stroke, run by KU Leuven at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In this study we want to develop and validate a PREM for patient with ischemic stroke. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ischemic Stroke
What is being tested?
Questionnaire
How many people
500 participants
Where
1 siteBelgium
Study dates
21 Feb 2023to 30 Sep 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Patients with ischemic stroke

Who may be able to join

  • > 18 years
  • ischemic stroke
  • stayed at least one day at the stroke unit

Who cannot join

  • not able to read the questionnaire
  • not able to answer question orally
  • are not proficient in the dutch language

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • KU Leuven

    Leuven, Flemish Brabant, 3000

Other trials in Belgium

About this study

Official title: Patient Experiences of the CVA Care Program on the Stroke Unit

In this study we want to develop and validate a PREM for patient with ischemic stroke.

Read the detailed description

Patient Reported Experience Measures (PREMs) assess patient's perception of health care. Currently, there is no suitable PREM tool for patients with ischemic stroke. Therefore, we aim to develop and validate a PREM for this patient population. This PREM will be validated in a multicentre study, in 10 Flemish hospitals. We want to investigate the feasibility of our new questionnaire, as well as the usefulness. In addition we well analyse the results of the questionnaires and use this information to improve the quality of the care program for stroke patients.

Conditions
Ischemic Stroke
Being tested
Questionnaire
Medical subject headings
Ischemic Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    Completion of the patient reported experience measurements (PREMs) questionnaire

Study groups in NCT05734352
Study groupRoleWhat they receive
InterventionCompletion of questionnaire
Receives: Other: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Validation of a new Patient Reported Experience Measurements (PREMs) for stroke patients

    Validation of a questionnaire which was developed based on literature and consensus meeting

    Measured: 6-months

Secondary outcomes (1)
  1. Patient experiences

    How do patients experience their received care when they are admitted to the stroke unit/neurology department

    Measured: 6-months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2023
  2. Study start21 Feb 2023
  3. Primary completion30 Sep 2024 (estimated)
  4. Study completion30 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05734352
Sponsor's protocol ID
BIC4STROKEPREMS
Acronym
BIC4CVAPREMS
Status last verified
Feb 2024
First submitted
8 Feb 2023
Last updated
7 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Ischemic Stroke, run by KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Validation of a new Patient Reported Experience Measurements (PREMs) for stroke patients (time frame: 6-months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in